Department of PET Diagnosis, Institute of Biomedical Research and Innovation, Minatojima-Minamimachi, Chuo-ku, Kobe, Japan.
Ann Nucl Med. 2011 Aug;25(7):511-9. doi: 10.1007/s12149-011-0496-9. Epub 2011 Jun 14.
To determine whether contrast-enhanced PET/CT is more accurate than either non-enhanced PET/CT or enhanced CT alone for nodal staging of uterine cancer.
Forty patients with endometrial cancer and cervical cancer underwent conventional PET/CT scan with low-dose CT (ldCT), followed by full-dose CT with IV contrast (ceCT) before radical hysterectomy with pelvic and, when applicable, para-aortic lymphadenectomy. Three data sets of PET/ldCT, PET/ceCT, and enhanced CT images were interpreted separately by two readers. For region-specific comparisons, para-aortic and pelvic lymph nodes were divided into the bilateral para-aortic, common iliac, external iliac, internal iliac, and obturator areas. Based on histopathological findings as the gold standard, we compared the diagnostic accuracy between the three methods using McNemar test with Bonferroni's adjustment.
Of the 40 patients, 21 underwent pelvic lymphadenectomy only. Region-based analysis showed that the sensitivity, specificity, and accuracy of PET/ceCT were 61.4% (27/44), 98.1% (308/314), and 93.6% (335/358), respectively, whereas those of PET/ldCT were 52.3% (23/44), 96.8% (304/314), and 91.3% (327/358), respectively, and those of enhanced CT were 40.9% (18/44), 97.8% (307/314), and 90.8% (325/358), respectively. Although PET/ceCT had the best sensitivity among the three imaging modalities, a significant difference was observed only between PET/ceCT and enhanced CT (p = 0.0027). Although PET/ceCT had better sensitivity and accuracy than PET/ldCT, the differences between the two imaging methods did not reach statistical significance (p = 0.046 and p = 0.047, respectively).
PET/ceCT is slightly but not significantly superior to PET/ldCT for nodal staging of uterine cancer. Nodal metastasis cannot be excluded even if PET/ceCT gives negative findings.
确定对比增强 PET/CT 与非增强 PET/CT 或增强 CT 单独用于子宫癌淋巴结分期相比是否更准确。
40 例子宫内膜癌和宫颈癌患者在根治性子宫切除术和骨盆(适当时行腹主动脉旁淋巴结切除术)前接受低剂量 CT(ldCT)常规 PET/CT 扫描,然后进行全剂量 CT 静脉造影(ceCT)。两位读者分别单独解读 PET/ldCT、PET/ceCT 和增强 CT 图像的三组数据。为了进行区域特异性比较,将腹主动脉旁和盆腔淋巴结分为双侧腹主动脉旁、髂总、髂外、髂内和闭孔区域。根据组织病理学发现作为金标准,我们使用 McNemar 检验和 Bonferroni 校正比较了三种方法之间的诊断准确性。
40 例患者中,21 例仅行盆腔淋巴结切除术。基于区域的分析表明,PET/ceCT 的灵敏度、特异性和准确性分别为 61.4%(27/44)、98.1%(308/314)和 93.6%(335/358),而 PET/ldCT 的灵敏度、特异性和准确性分别为 52.3%(23/44)、96.8%(304/314)和 91.3%(327/358),增强 CT 的灵敏度、特异性和准确性分别为 40.9%(18/44)、97.8%(307/314)和 90.8%(325/358)。虽然三种成像方式中 PET/ceCT 的灵敏度最高,但仅 PET/ceCT 与增强 CT 之间存在显著差异(p=0.0027)。虽然 PET/ceCT 的灵敏度和准确性均优于 PET/ldCT,但两种成像方法之间的差异无统计学意义(p=0.046 和 p=0.047)。
对于子宫癌的淋巴结分期,PET/ceCT 略优于 PET/ldCT,但无统计学意义。即使 PET/ceCT 结果为阴性,也不能排除淋巴结转移。